These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 11362202)

  • 21. Changes in plasma human immunodeficiency virus type 1 RNA associated with herpes simplex virus reactivation and suppression.
    Schacker T; Zeh J; Hu H; Shaughnessy M; Corey L
    J Infect Dis; 2002 Dec; 186(12):1718-25. PubMed ID: 12447756
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Valacyclovir for the treatment of genital herpes.
    Brantley JS; Hicks L; Sra K; Tyring SK
    Expert Rev Anti Infect Ther; 2006 Jun; 4(3):367-76. PubMed ID: 16771614
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of HSV in the transmission and progression of HIV.
    Schacker T
    Herpes; 2001 Jul; 8(2):46-9. PubMed ID: 11867018
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Maternal herpes simplex virus type 2 coinfection increases the risk of perinatal HIV transmission: possibility to further decrease transmission?
    Bollen LJ; Whitehead SJ; Mock PA; Leelawiwat W; Asavapiriyanont S; Chalermchockchareonkit A; Vanprapar N; Chotpitayasunondh T; McNicholl JM; Tappero JW; Shaffer N; Chuachoowong R
    AIDS; 2008 Jun; 22(10):1169-76. PubMed ID: 18525263
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acyclovir suppression to prevent recurrent genital herpes at delivery.
    Scott LL; Hollier LM; McIntire D; Sanchez PJ; Jackson GL; Wendel GD
    Infect Dis Obstet Gynecol; 2002; 10(2):71-7. PubMed ID: 12530483
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Herpes zoster infection as an immune reconstitution inflammatory syndrome in HIV-seropositive subjects: a review.
    Feller L; Wood NH; Lemmer J
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Oct; 104(4):455-60. PubMed ID: 17604657
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Valacyclovir for the suppression of recurrent genital herpes in human immunodeficiency virus-infected subjects.
    DeJesus E; Wald A; Warren T; Schacker TW; Trottier S; Shahmanesh M; Hill JL; Brennan CA;
    J Infect Dis; 2003 Oct; 188(7):1009-16. PubMed ID: 14513421
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of acyclovir on herpes virus infection and susceptibility of isolated virus to acyclovir.
    Muto S; Suzuki H; Yokota T; Shigeta S
    Fukushima J Med Sci; 1984 Feb; 30(1):19-27. PubMed ID: 6096237
    [No Abstract]   [Full Text] [Related]  

  • 29. Improvement in healing and reduction in HIV shedding with episodic acyclovir therapy as part of syndromic management among men: a randomized, controlled trial.
    Paz-Bailey G; Sternberg M; Puren AJ; Markowitz LE; Ballard R; Delany S; Hawkes S; Nwanyanwu O; Ryan C; Lewis DA
    J Infect Dis; 2009 Oct; 200(7):1039-49. PubMed ID: 19715417
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Global epidemiology of sexually transmitted diseases.
    Da Ros CT; Schmitt Cda S
    Asian J Androl; 2008 Jan; 10(1):110-4. PubMed ID: 18087650
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prolonged herpes zoster in a patient infected with the human immunodeficiency virus.
    Matsuo K; Honda M; Shiraki K; Niimura M
    J Dermatol; 2001 Dec; 28(12):728-33. PubMed ID: 11804069
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Skin conditions common to people with HIV infection or AIDS.
    Kalibala S
    AIDS Action; 1990 Apr; (10):2-3. PubMed ID: 12342834
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acyclovir suppression to prevent clinical recurrences at delivery after first episode genital herpes in pregnancy: an open-label trial.
    Scott LL; Hollier LM; McIntire D; Sanchez PJ; Jackson GL; Wendel GD
    Infect Dis Obstet Gynecol; 2001; 9(2):75-80. PubMed ID: 11495557
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and safety of valacyclovir for the suppression and episodic treatment of herpes simplex virus in patients with HIV.
    Warren T; Harris J; Brennan CA
    Clin Infect Dis; 2004 Nov; 39 Suppl 5():S258-66. PubMed ID: 15494897
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevention of herpes simplex virus type 2 transmission with antiviral therapy.
    Corey L; Ashley R;
    Herpes; 2004 Aug; 11 Suppl 3():170A-174A. PubMed ID: 15319087
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Topical microbicides for the prevention of genital herpes infection.
    Keller MJ; Tuyama A; Carlucci MJ; Herold BC
    J Antimicrob Chemother; 2005 Apr; 55(4):420-3. PubMed ID: 15743896
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Mother-infant and indirect transmission of HSV infection: treatment and prevention].
    Henrot A
    Ann Dermatol Venereol; 2002 Apr; 129(4 Pt 2):533-49. PubMed ID: 12122323
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Tuberculosis in compromised hosts].
    Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Sacral myeloradiculitis complicating genital herpes in a HIV-infected patient.
    Corral I; Quereda C; Navas E; Pérez-Elias MJ; Jover F; Moreno S
    Int J STD AIDS; 2005 Feb; 16(2):175-7. PubMed ID: 15807949
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of multiple herpesvirus infections on the progression of HIV disease in a cohort of HIV seroconverters.
    Suligoi B; Dorrucci M; Uccella I; Andreoni M; Rezza G;
    J Med Virol; 2003 Feb; 69(2):182-7. PubMed ID: 12683405
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.